Virbac Unveils Canine Cephalexin Tablet

Posted: Sept. 5, 2012, 8:05 p.m. EDT


Virbac Animal Health of Fort Worth, Texas, launched the first chewable cephalexin tablet designed exclusively for dogs, the company reported Tuesday.

The FDA-approved drug, called Rilexine, is indicated for the treatment of secondary superficial bacterial pyoderma in dogs caused by susceptible strains of Staphylococcus pseudintermedius.

Previously, veterinarians often relied on the generic human form of cephalexin to treat dogs, but Rilexine is the first drug of its kind approved by the U.S. Food and Drug administration for the veterinary market, Virbac reported. The new drug should overcome some of the drawbacks of prescribing human cephalexin off-label, including a bitter, metallic taste and strong odor, a lack of veterinary-specific guidelines and the inability to tailor doses, Virbac noted.

Pyoderma is one of the most common diseases seen in dogs, and secondary superficial bacterial pyoderma is the most common form of pyoderma, according to Virbac.

Rilexine is available in 150 mg, 300 mg and 600 mg scored doses. The drug should not be prescribed to dogs that have a known allergy to cephalexin or the B-lactam group of antibiotics.


Edit Module
Edit ModuleShow Tags

Archive »Read More

Penn Vet Teams Up With N.J. Hospital

Mount Laurel Animal Hospital is the first participant in the Penn Vet Affiliates program.

RCVS Enhances Hospital Accreditation System

British veterinary practices can earn “Good” or “Outstanding” awards.

Georgia Opens VetCAMP 2016 Registration

The Veterinary Career Aptitude and Mentoring Program (VetCAMP) is a weeklong opportunity for high school students to explore the field of veterinary medicine.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags


Show More...
Edit Module
Edit Module
Edit Module